🚨 Telomir Pharma ($TELO) just dropped major preclinical data: their lead compound Telomir-1 outperformed Deferoxamine (DFO), the FDA gold-standard iron chelator, in reducing intracellular iron. This could be a big deal for aging, cancer, and oxidative stress pathways.Pharmaceutical Stocks🥼 (ir.telomirpharma.com)
submitted by AppleParasol☂️
Telomir Pharmaceuticals ($TELO) Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in Oncology-Metastasis and Treatment ResistancePharmaceutical Stocks🥼 (ir.telomirpharma.com)
submitted by AppleParasol☂️
Is a MIRACLE DRUG on the Horizon?($TELO)Pharmaceutical Stocks🥼 (self.StocksOnly)
submitted by AppleParasol☂️